HIGHLIGHTS FROM ENETS 2024
Your direct line with Vienna
With the educational support of:
Congress highlights
Prof Timon van Damme, digestive oncologist from the University Hospital Antwerp, provides a comprehensive overview of the third day at the ENETS conference held in Vienna in March 2024. The
Prof Alain Hendlisz, Associate Head of the Department of GI Oncology at Hospital Universitaire de Bruxelles, provides insights from the first day of the ENETS 2024 meeting.
The first study,
Prof Ivan Borbath from the University Hospitals Saint-Luc in Brussels covered the first day of the ENETS 2024, a postgraduate course. The first session was marked with a focus
In the spotlight
Prof Christophe Deroose, a prominent nuclear medicine physician and physician-scientist at UZ Leuven, provides insights from the ENETS session on patient selection for peptide-receptor radionuclide therapy (PRRT), a potent treatment
Prof Timon van Damme, a digestive oncologist at the University Hospital in Antwerp, discusses the groundbreaking NETTER-2 trial presented by Prof. Wouter de Herder from Erasmus MC Hospital, Rotterdam at